Summary
Merck & Co., Inc. (MRK) announced the departure of Mr. Adam Schechter, Executive Vice President and President of Global Human Health, effective December 31, 2018. Mr. Schechter will transition to a special advisor role before leaving the company. This change is part of a broader restructuring and elimination of his position within the organization. In connection with his departure, Mr. Schechter is eligible for benefits under Merck's U.S. Separation Benefits Plan, which includes 78 weeks of separation pay and certain health and welfare benefits, contingent on signing a release and adhering to restrictive covenants. Additionally, Merck will pay Mr. Schechter $1,000,000 for a one-year non-competition agreement, underscoring the strategic importance of retaining competitive advantage.
Key Highlights
- 1Adam Schechter, EVP and President of Global Human Health, is departing effective December 31, 2018.
- 2Mr. Schechter will serve as a special advisor before his departure.
- 3His position is being eliminated as part of a company restructuring.
- 4Mr. Schechter will receive 78 weeks of separation pay and health benefits.
- 5A $1,000,000 payment will be made for a one-year non-competition agreement.
- 6Benefits are contingent on signing a release of claims and adhering to restrictive covenants.